Lymphocyte transformation and leucocyte migration-inhibition by Australia antigen.
- 1 September 1973
- journal article
- Vol. 15 (1) , 27-34
Abstract
The occurrence of a state of cell-mediated immune responsiveness to the Australia antigen following acute virus-B hepatitis has been demonstrated by the use of two in vitro methods—the lymphocyte transformation test and the leucocyte migration–inhibition test. Australia antigen-rich serum and purified Australia antigen were found to be effective agents in both tests. Close correlation was observed between the two tests. Persistent carriers of the Australia antigen give negative results with both tests.This publication has 19 references indexed in Scilit:
- RELATION BETWEEN AUSTRALIA ANTIGEN AND AUTOIMMUNE HEPATITISThe Lancet, 1972
- Antibody to hepatitis-associated antigen. Frequency and pattern of response as detected by radioimmunoprecipitationPublished by American Medical Association (AMA) ,1972
- CELLULAR IMMUNITY AND HEPATITIS-ASSOCIATED, AUSTRALIA ANTIGEN LIVER DISEASEThe Lancet, 1972
- Hepatitis-associated Antigen and Antibody in Uganda: Correlation of Serological Testing with HistopathologyBMJ, 1972
- LYMPHOCYTE TRANSFORMATION BY AUSTRALIA ANTIGENThe Lancet, 1971
- HEPATITIS-ASSOCIATED ANTIGEN IN UGANDAN PATIENTS WITH HEPATOCELLULAR CARCINOMAThe Lancet, 1970
- CHRONIC LIVER DISEASE AND PRIMARY LIVER-CELL CANCER WITH HEPATITIS-ASSOCIATED (AUSTRALIA) ANTIGEN IN SERUMThe Lancet, 1970
- Australia antigen and hepatitis. Studies in asymptomatic people and lepromatous leprosy patientArchives of internal medicine (1960), 1970
- AUSTRALIA ANTIGEN IN ACUTE AND CHRONIC LIVER DISEASEThe Lancet, 1969
- Human Lymphocyte Migration as a Parameter of HypersensitivityActa Medica Scandinavica, 1967